VACUNAS CANDIDATAS
COVID-19

3 nanopartículas lipídicas de ARNm

BioNTech/Fosun Pharma/Pfizer

socio CAEME

Inactivada

Wuhan Institute of Biological Products/Sinopharm

ChAdOx1-S

University of Oxford/AstraZeneca

socio CAEME

Gam-COVID-Vac Adeno-based

Gamaleya Research Institute

Ad26 – Adenovirus recombinante serotipo 26

Janssen Pharmaceutical Companies

socio CAEME

ARNm encapsulado en nanopartículas lipídicas (LNP)

Moderna/NIAID

Inactivada + alumbre

Sinovac

Inactivada

Beijing Institute of Biological Products/Sinopharm

Vector de adenovirus tipo 5

CanSino Biological Inc./Beijing Institute of Biotechnology

Whole-Virion Inactivated

Bharat Biotech

Vacuna de nanopartículas de glucoproteína del CoV-2 SARS, recombinante, de longitud completa, adyuvada con Matrix M

Novavax

SARS-CoV-2 mRNA vaccine (ARCoV)

Walvax Biotechnology and Suzhou Abogen Biosciences

Proteína recombinante, adyuvada (Dímero RBD)

Anhui Zhifei Longcom Biopharmaceutical/ Institute of Microbiology Chinese Academy of Sciences

VLA2001

Valneva / National Institute for Health Research / United Kingdom

ARNm

Curevac

Inactivated SARS-CoV-2 vaccine (Vero cell)

Shenzhen Kangtai Biological Products Co Ltd.

EpiVacCorona (EpiVacCorona vaccine based on peptide antigens for the prevention of COVID-19)

Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector"

Inactivada

Chinese Academy of Medical Sciences

CIGB-66 (RBD+aluminium hydroxide)  

Center for Genetic Engineering and Biotechnology (CIGB)

Inactivada

Research Institute for Biological Safety Problems/Rep of Kazakhstan

Vacuna de ADN plasmídico

Osaka University/ AnGes/ Takara Bio

Vacuna de ADN plasmídico

Zydus Cadila

Vacuna de ADN plasmídico con electroporación

Inovio Pharmaceuticals

UB-612 (Multitope peptide based S1-RBD-protein based vaccine)

Vaxxinity

COVAX-19® Recombinant spike protein + adjuvant

Vaxine Pty Ltd./CinnaGen Co

Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)

Guangdong Provincial Center for Disease Control and Prevention/Gaozhou Center for Disease Control and Prevention

COVAC-1 and COVAC-2 sub-unit vaccine (spike protein) + SWE adjuvant

University of Saskatchewan

Razi Cov Pars, recombinant spike protein

Razi Vaccine and Serum Research Institute

Inactivada

Beijing Minhai Biotechnology Co. Ltd.

Vacuna basada en ADN (GX-19)

Genexine Consortium

Basada en RBD

Kentucky Bioprocessing

COVID-eVax, a candidate plasmid DNA vaccine of the Spike protein

Takis + Rottapharm Biotech

Proteína S (producción de baculovirus)

Sanofi Pasteur/GSK

socio CAEME

Inactivated (NDV-based) chimeric vaccine with or without the adjuvant CpG 1018

The Government Pharmaceutical Organization (GPO) / PATH / Dynavax

GLS-5310

GeneOne Life Science

SC-Ad6-1, Adneviral vector vaccine

Tetherex Pharmaceuticals Corporation

AdCLD-CoV19 (adenovirus vector)

Cellid Co / Ltd

Subunidad de Proteína Potenciada (RBD)

Biological E Ltd

Recombinant Sars-CoV-2 Spike protein, Aluminum adjuvanted (Nanocovax)

Nanogen Pharmaceutical Biotechnology

Recombinant SARS-CoV-2 Vaccine (CHO cell)

National Vaccine and Serum Institute China

SARS-CoV-2-RBD-Fc fusion protein

University Medical Center Groningen + Akston Biosciences Inc.

VSV-S

Israel Institute for Biological Research/Weizmann Institute of Science

ARCT-021 

Arcturus/Duke-NUS

Recombinant protein vaccine S-268019 (using Baculovirus expression vector system)

Shionogi

COVIVAC. Newcastle Disease Virus (NDV) expressing membrane-anchored pre-fusion-stabilized trimeric SARS-CoV-2 S protein +/- adjuvant CpG 1018

Institute of Vaccines and Medical Biologicals / Vietnam

Dendritic cell vaccine AV-COVID-19. A vaccine consisting of autologous dendritic cells loaded with antigens from SARS-CoV-2, with or without GM-CSF

Aivita Biomedical Inc / National Institute of Health Research and Development / Ministry of Health Republic of Indonesia

CIGB-669 (RBD+AgnHB)

Center for Genetic Engineering and Biotechnology (CIGB)

LV-SMENP-DC vaccine. Dendritic cells are modified with lentivirus vectors expressing Covid-19 minigene SMENP and immune modulatory genes. CTLs are activated by LV-DC presenting Covid-19 specific antigens.

Shenzhen Geno-Immune Medical Institute

GBP510, a recombinant surface protein vaccine with adjuvant AS03 (aluminium hydroxide)

SK Bioscience Co Ltd and CEPI

EuCorVac-19; A spike protein using the recombinant protein technology and with an adjuvant.

POP Biotechnologies and EuBiologics Co Ltd

RBD-HBsAg VLPs

SpyBiotech/Serum Institute of India

CORVax – Spike (S) Protein Plasmid DNA Vaccine

Providence Health & Services

Chimpanzee Adenovirus serotype 68 (ChAd) and self-amplifying mRNA (SAM) vectors expressing spike alone, or spike plus additional SARS-CoV-2 T cell epitopes.

Gritstone Oncology 

COH04S1 (MVA-SARS-2-S) – Modified vaccinia ankara (sMVA) platform + synthetic SARS-CoV-2

City of Hope Medical Center + National Cancer Institute

CoV2 SAM (LNP) vaccine. A self-amplifying mRNA (SAM) lipid nanoparticle (LNP) platform + Spike antigen

GlaxoSmithKline

COVIGEN 

University of Sydney / Bionet Co / Ltd Technovalia

CoV2-OGEN1, protein-based vaccine

VaxForm

Adjuvanted inactivated vaccine against SARS-CoV-2

The Scientific and Technological Research Council of Turkey (TÜBITAK)

MV-014-212, a live attenuated vaccine that expresses the spike (S) protein of SARS-CoV-2

Meissa Vaccines / Inc.

AdimrSC-2f (recombinant RBD +/- Aluminium)

Adimmune Corporation

Live recombinant Newcastle Disease Virus (rNDV) vector vaccine

Laboratorio Avi-Mex

CoVepiT vaccine: SARS-CoV-2 multi-target peptide vaccine (targeting Spike, M, N, and several non-structural proteins)

OSE immunotherapeutics

ReCOV: Recombinant two-component spike and RBD protein COVID-19 vaccine (CHO cell).

Jiangsu Rec-Biotechnology

ChulaCov19 mRNA vaccine

Chulalongkorn University

Covid-19/aAPC vaccine. The Covid-19/aAPC vaccine is prepared by applying lentivirus modification with immune modulatory genes and the viral minigenes to the artificial antigen presenting cells (aAPCs).

Shenzhen Geno-Immune Medical Institute

SpFN (spike ferritin nanoparticle) uses spike proteins with a liposomal formulation QS21 (ALFQ) adjuvant.

Walter Reed Army Institute of Research (WRAIR)

MF59 adjuvanted SARS-CoV-2 Sclamp vaccine 

The University of Queensland

Tecnología de Virus quimérico VSV apto para replicación (VSVΔG) que administra la glucoproteína de la Espiga (S) del SARS-CoV-2.

IAVI/Merck

socio CAEME

SK SARS-CoV-2 recombinant surface antigen protein subunit (NBP2001) + adjuvanted with alum.

SK Bioscience Co Ltd

Inactivated SARS-CoV-2 vaccine FAKHRAVAC (MIVAC)

Organization of Defensive Innovation and Research

Codificación de vector adenoviral simio de replicación defectuosa (GRAd) SARS-CoV-2 S

ReiThera/LEUKOCARE/Univercells

Ad5-nCoV

Institute of Biotechnology/ Academy of Military Medical Sciences/ PLA of China

Plataforma de vacuna oral

Vaxart

MVA-SARS-2-S

Ludwig-Maximilians/ University of Munich

Vacuna de subunidad de proteína S trimérica similar a la nativa

Clover Biopharmaceuticals Inc/GSK/Dynavax

socio CAEME

Proteína S recombinante con Advax ™ potenciador

Vaxine Pty Ltd/Medytox

Proteína S estabilizada por pinza molecular

University of Queensland/CSL/Seqirus

socio CAEME

Proteína S-2P + CpG 1018

Medigen Vaccine Biologics Corporation/NIAID/Dynavax

rRBD produced in CHO-cell chemically conjugate to tetanus toxoid

Instituto Finlay de Vacunas Cuba

RBD + Adjuvant

Instituto Finlay de Vacunas Cuba

ARNm

FBRI SRC VB VECTOR Rospotrebnadzor Koltsovo

RBD (baculovirus production expressed in Sf9 cells)

West China Hospital/ Sichuan University

SARS-CoV-2 HLA-DR peptides

University Hospital Tuebingen

S1-RBD-protein

COVAXX

bacTRL-Spike

Symvivo

V591-001 – Measles-vector based (TMV-o38)

Institute Pasteur/Themis/Univ of Pittsburg Center for Vaccine Research/Merck

socio CAEME

Intranasal flu-based-RBD

Beijing Wantai Biological Pharmacy/ Xiamen University

saRNA

Imperial College London

ARNm

People's Liberation Army (PLA) Academy of Military Sciences/Walvax Biotech.

[E1-, E2b-, E3-] hAd5- COVID19- Spike/nucleocápside

ImmunityBio Inc & NantKwest Inc

VLP vegetal

Medicago Inc.

DNA, engineered vaccine inserts compatible with multiple delivery systems

DIOSynVax Ltd / University of Cambridge

Live attenuated bacterial (Pertussis) Vector

Institut Pasteur Lille / Inserm

The 3 regions of SARS-Cov-2 Spike-protein: NTD, RBD and HR1-HR2 inserted into the plasmid of PcDNA3.1 (+).

Center of Genomics and Bioinformatics of Academy of Science of Republic of Uzbekistan

Live attenuated bacterial vector

ALtraBio / TheRex

msDNA vaccine

Mediphage Bioceuticals/University of Waterloo

DNA Immunostimulatory sequences

Inserm

DNA plasmid  vaccine encoding RBD

Vaccibody / Oslo Research Park / Norway

Recombinant, prefusion stabilized SARS-CoV-2 Spike antigen

Medigen Vaccines Biologics Corp (MVC)/Vaxess Technologies (MIMIX)

Protein peptides with alum

Hacettepe University Turkey

Recombinant protein RBD fusion dimer adjuvanted vaccine (COVID-19 Vaccine Hipra)

HIPRA SCIENTIFIC SLU; LABORATORIOS HIPRA SA

S protein integrated in HIV VLPs

IrsiCaixa AIDS Research/IRTACReSA/Barcelona Supercomputing Centre/Grifols

Péptidos VLP / virus completo

Univ of Sao Paulo

Desconocida

Tulane University

ZIP1642 is a self-amplifying RNA vaccine encapsulated in an LNP, which encodes for multiple antigens, including the Spike (S) protein.

Ziphius Vaccines and Ghent University

eVLP – Partícula pseudovírica envolvente

ARTES Biotechnology

Encapsulated mRNA

CEA

Development of recombinant protein based S1 and S2 (Spike) and nucleocapsid subunits vaccines using a plant expression vector.

Akdeniz University Department of Agricultural Biotechnology Antalya Turkey

Recombinant protein subunit vaccine

Pharmada Pharmaceuticals/TURKEY

Replicating VSV vector-based DC-targeting

University of Manitoba

Intranasal Newcastle disease virus vector (rNDV-LS1-FARVET) expressing S1 protein: rNDV-LS1-S1-F/SARS-CoV-2

Farmacológicos Veterinarios SAC (FARVET SAC)

VLP

OSIVAX

Intranasal Newcastle disease virus vector (rNDV-LS1-FARVET) expressing RBD protein: rNDV-LS1-HN-RBD/SARS-CoV-2

Farmacológicos Veterinarios SAC (FARVET SAC)

Recombinant SARS CoV-2 RBD Protein, Alum adjuvanted

Bio Farma + Baylor College Medicine

Lentiviral Vector

Theravectys – Institut Pasteur

Recombinant Protein Vaccine

Ataturk University Vaccine Research Center (Erzurum) and Health Institutes of Turkey (TUSEB)

Recombinant Spike Protein

CinnaGen Co

Protein Subunit Adenoviral Carrier

CEA CNRS

Protein Subunit Nanoformulated

Vaxinano CEA INRAE

Soluble recombinant S protein produced in CHO cells

Center for Advanced Technologies Uzbekistan

Adjuvanted Peptides + Recombinant Spike Protein

Yıldız Technical University Turkey

NYVAC-KC, attenuated vaccinia virus vector expressing SARS-CoV-2 Spike and other viral proteins

Arizona State University

Desconocida

Doherty Institute

ADDomerTM con display de multiepítopo

Imophoron Ltd and Bristol University’s Max Planck Centre

Protein DC-targeted epitopes

LinkinVax VRI Inserm

Lentiviral Vector Retro-VLP Particles

Sorbonne University

Partículas pseudovíricas, basada en RBD de VLP

Saiba GmbH

Sendai virus vector

Max Planck Institute for Biochemstry / vir4vac Germany

Spiked-based

Nanografi Nano Technology Middle East Technical University Ankara University

Lentiviral Vector

AIOVA

Adenovirus Type 5 Vector

Globe Biotech Limited / Bangladesh

Sendai virus vector

ID Pharma

Codon deoptimized live attenuated vaccines

Mehmet Ali Aydinlar University / Acıbadem Labmed Health Services A.S

Egg-based, inactivated, whole chimeric Newcastle Disease Virus (NDV) expressing membrane-anchored pre-fusion-stabilized trimeric SARS-CoV-2 S protein (Hexapro) + CpG 1018

Institute Butantan (Brazil) / Dynavax / PATH

Cross-reactive T-cell recombinant vaccine based on SARS-CoV-2 nucleoprotein (N) expressed in E.coli

FSUE SPbSRIVS FMBA of Russia (St. Petersburg Institute of Vaccines)

Partículas pseudovíricas, vehículos lentivirus y baculovirus

Oncoimmunology group

VLP + adyuvante

Mahidol University/ The Government Pharmaceutical Organization (GPO)

DNA plasmids containing S-gene

Biosun Pharmed

Adeno5-based

Erciyes University

mRNA

Selcuk University

ARNm

IDIBAPS-Hospital Clinic Spain

RBD-protein

Mynvax

Peptide + novel adjuvant

Bogazici University

Inactivada

Erciyes University

Newcastle disease virus expressing membrane-anchored spike

Icahn School of Medicine at Mount Sinai

Inactivated whole virus

National Research Centre/Egypt

ARNm

Greenlight Biosciences

ARNm en sistema de administración intranasal

eTheRNA

Recombinant S protein

Max-Planck-Institute of Colloids and Interfaces

Self-amplifying RNA

Gennova

RBD protein delivered in mannoseconjugated chitosan nanoparticle

Ohio State University / Kazakh National Agrarian University

DNA plasmid vaccine S,S1,S2,RBD &N

National Research Centre/Egypt

ARNm de LNP

Chula Vaccine Research Center/University of Pennsylvania

VSV-S

Aurobindo

Peptides

Neo7Logic

Enveloped Virus-Like Particle (eVLP)

VBI Vaccines Inc.

Recombinant spike protein with Essai O/W 1849101 adjuvant

Kazakh National Agrarian University Kazakhstan / National Scientific Center for Especially Dangerous Infections

ARNm

China CDC/Tongji University/Stermina

VLP

Middle East Technical University

Recombinant S protein

Izmir Biomedicine and Genome Center

Inactivated + Alum

Shifa Pharmed

Protein Subunit S,N,M&S1 protein

National Research Centre/Egypt

Inactivada

Selcuk University

Virus-like particle-based Dendritic Cell(DC)- targeting vaccine

University of Manitoba

Inactivated

Zista Kian Azma Co

Egg-based, inactivated, whole chimeric Newcastle Disease Virus (NDV) expressing membrane-anchored pre-fusion-stabilized trimeric SARS-CoV-2 S protein (Hexapro) + CpG 1018

Institute of Vaccines and Medical Biologicals (IVAC; Vietnam) / Dynavax / PATH

Plant derived VLP

Shiraz University

Recombinant S protein produced in BEVS

Tampere University

Varios candidatos de ARNm

RNAimmune Inc

VLP

Bezmialem Vakif University

MVA expressing structural proteins

Centro Nacional Biotecnología (CNB-CSIC) Spain

RBD protein (baculovirus production) + FARSqualene adjuvant

Farmacológicos Veterinarios SAC (FARVET SAC) / Universidad Peruana Cayetano Heredia (UPCH)

D614G variant LNP-encapsulated mRNA

Globe Biotech Ltd

ARNm encapsulado en liposomas

BIOCAD

ARNm encapsulado en LNP

University of Tokyo/ Daiichi- Sankyo

Adenovirus-based

Ankara University

Influenza A H1N1 vector

National Research Centre/Egypt

S-Protein (Subunit) + Adjuvant, E coli based Expression

Helix Biogen Consult. Ogbomoso & Trinity Immonoefficient Laboratory/Ogbomoso. Oyo State/Nigeria.

Replicación de ARN derivados de SARS-CoV-2 defectuoso

Centro Nacional Biotecnología (CNB-CSIC) Spain

DNA vaccine

Ege University

ARNm encapsulado en LNP que codifica RBD

Fudan University/ Shanghai JiaoTong University/RNACure Biopharma

Cóctel de ARNm encapsulado en LNP que codifica VLP

Fudan University/ Shanghai JiaoTong University/RNACure Biopharma

LNP-mRNA

CanSino Biologics/Precision NanoSystems

ARNm de LNP

Translate Bio/Sanofi Pasteur

socio CAEME

DNA plasmid vaccine RBD&N

Scancell/University of Nottingham/ Nottingham Trent University

Subunidad proteica

Research Institute for Biological Safety Problems/Rep of Kazakhstan

Vector de paramixovirus aviar (APMV)

The Lancaster University UK

S subunit intranasal liposomal formulation with GLA/3M052 adjs.

University of Virginia

Recombinant protein

Yisheng Biopharma

Oral Salmonella enteritidis (3934Vac) based protein expression system of RBD

Farmacológicos Veterinarios SAC (FARVET SAC) / Universidad Peruana Cayetano Heredia (UPCH)

Vector del virus de la enfermedad de Newcastle (NDV- SARS-CoV-2/Espiga)

Intravacc/ Wageningen Bioveterinary Research/Utrecht Univ

Inactivated

Milad Pharmaceutics Co

Vector de influenza de replicación única sin M2

UW–Madison/FluGen/Bharat Biotech

Inactivated + alum

KM Biologics

Vector VSV

FBRI SRC VB VECTOR Rospotrebnadzor Koltsovo

VSV-S

University of Western Ontario

Vector de influenza expresando RBD

University of Hong Kong

Influenza atenuada que expresa una porción antigénica de la proteína S

Fundação Oswaldo Cruz and Instituto Buntantan

Inactivada

Kocak Farma Ilac ve Kimya San. A.S.

Egg-based, inactivated, whole chimeric Newcastle Disease Virus (NDV) expressing membrane-anchored pre-fusion-stabilized trimeric SARS-CoV-2 S protein (Hexapro) + CpG 1018

Government Pharmaceutical Organization (GPO; Thailand) / Dynavax / PATH

Ad 5 vector for intranasal administration

University of Helsinki & University of Eastern Finland

Vacuna recombinante basada en el virus de la influenza A, para la prevención de COVID- 19 (intranasal)

FBRI SRC VB VECTOR Rospotrebnadzor Koltsovo

Vacuna viva viral vectorizada basada en la cadena atenuada del virus de la influenza (intranasal)

BiOCAD and IEM

Vector de HSPV expresando proteína S

Tonix Pharma/Southern Research

Virus del sarampión (objetivos S, N)

DZIF – German Center for Infection Research

mRNA

Providence Therapeutics

Vector de sarampión

FBRI SRC VB VECTOR Rospotrebnadzor Koltsovo

DNA plasmid vaccine

Globe Biotech Limited / Bangladesh

Vector de sarampión

Zydus Cadila

Vector YF17D

KU Leuven

Basada en espiga (barrido de epítopo)

ImmunoPrecise

Péptido de vesícula de membrana externa (OMV)

Intravacc/Epivax

Subunidad de vesícula de membrana externa (OMV)

Intravacc/Epivax

Basada en RBD

Neovii/Tel Aviv University

Subunidad proteica

MOGAM Institute for Biomedical Research GC Pharma

Péptidos derivados de Proteína de espiga

Axon Neuroscience SE

Administración oral, subunidad estable al calor

Applied Biotechnology Institute Inc

Proteína S recombinante en sistema de vector de expresión de baculovirus de células de insecto (IC-BEVS)

Vabiotech

Proteína de fusión recombinante S1-Fc

AnyGo Technology

Basado en espiga

University of Alberta

Partículas esféricas estructuralmente modificadas del virus del mosaico del tabaco (TMV)

Lomonosov Moscow State University

Vacuna basada en OMV

BiOMViS Srl/Univ of Trento

Plasmid DNA, Needle-Free Delivery

Immunomic Therapeutics Inc./EpiVax Inc.

LNP-encapsulated mRNA encoding S

Max-Planck-Institute of Colloids and Interfaces

Plasmid DNA, nanostructured RBD

National institute of Chemistry Slovenia

Vacuna basada en OMV

Quadram Institute Biosciences

Subunidad basada en vegetales (RBD-Fc + Adyuvante)

Baiya Phytopharm/ Chula Vaccine Research Center

Vacuna de nanopartículas

LakePharma Inc.

Sistema de expresión de proteínas S y N basado en vacunal oral E. coli

MIGAL Galilee Research Institute

mRNA

Cell Tech Pharmed

Vacuna candidata de péptido largo sintético para proteínas S y M

OncoGen

Potenciada – péptido de microesferas

VIDO-InterVac University of Saskatchewan

COVID-19 XWG-03 – proteínas truncadas S (espiga)

Innovax/Xiamen Univ/GSK

socio CAEME

Proteína recombinante, nanopartículas (a base de proteína S y otros epítopos)

Saint-Petersburg scientific research institute of vaccines and serums

Subunidad proteica, Fuente vegetal

iBio/CC-Pharming

Proteína S1 o RBD

Baylor College of Medicine

Vacuna de subunidades

FBRI SRC VB VECTOR Rospotrebnadzor Koltsovo

Cadena principal gp-96

Heat Biologics/Univ. Of Miami

Vacuna peptídica

FBRI SRC VB VECTOR Rospotrebnadzor Koltsovo

Subunidad de Proteína EPV- CoV-19

EpiVax

saRNA formulated in a NLC

Infectious Disease Research Institute/ Amyris Inc

Proteína S

EpiVax/Univ of Georgia

Péptido Ii-Key

Generex/EpiVax

Proteína S

AJ Vaccines

Péptido

Flow Pharma Inc

Péptido

Vaxil Bio

Subunidad S1 con Matriz de microagujas

University of Pittsburgh

Proteína recombinante de VLP + adyuvante

Japan

Proteína S + adyuvante

National Institute of Infectious Disease Japan

Proteína S

WRAIR/USAMRIID

Antígenos peptídicos formulados en LNP

IMV Inc

VLP del sistema de expresión de células S2 de insecto Drosophila

ExpreS2ion

Partícula tipo cápside

AdaptVac (PREVENT-nCoV consortium)

Dominio de unión al receptor (RBD) en la proteína de fusión con región constante (Fc) de la inmunoglobulina G (IgG) + Adyuvante.

Chulalongkorn University/GPO Thailand

Subunidad proteica

University of San Martin and CONICET Argentina

Vacuna inactivada contra el SARS-CoV2 basada en influenza + Potenciador

National Center for Genetic Engineering and Biotechnology (BIOTEC) /GPO Thailand

viral de la rabia recombinante desactivada que contiene S1

Bharat Biotech/Thomas Jefferson University

Vacuna basada en el virus de la parainfluenza 5 (PIV5) que expresa la proteína S

University of Georgia/University of Iowa

Measles Vector

Cadila Healthcare Limited

Vacuna basada en células dendríticas

University of Manitoba

Proteínas estructurales que expresan MVA

Centro Nacional Biotecnología (CNB-CSIC)

basada en adenovirus + péptidos unidos al antígeno leucocitario humano (HLA)

Valo Therapeutics Ltd

Ad5 S oral

Stabilitech Biopharma Ltd

Ad5 S (plataforma GREVAX™)

Greffex

Recombinant spike with adjuvant

Iran

NasoVAX basada en adenovirus que expresa la proteína S de SARS2-CoV

Altimmune

MVA-S

IDIBAPS-Hospital Clinic Spain

Codificada con MVA-S

DZIF – German Center for Infection Research

Partículas pseudovíricas (VLP) codificadas con MVA

GeoVax/BravoVax

Vector de virus adeno-asociado (AAVCOVID)

Massachusetts Eye and Ear/Massachusetts General Hospital/AveXis

Newcastle disease virus expressing S

Icahn School of Medicine at Mount Sinai

Vacuna viva atenuada desoptimizada por codones

Indian Immunologicals Ltd/Griffith University

Vacuna viva atenuada desoptimizada por codones

Codagenix/Serum Institute of India

mRNA

ReNAP Co

Inactivada + CpG 1018

Valneva/Dynavax

Inactivada + CpG 1018

Sinovac/Dynavax

TBD

Osaka University/ BIKEN/ NIBIOHN

Vacuna de ADN

Entos Pharmaceuticals

Vacuna de ADN

University of Waterloo

ADN plasmídico, de inyección sin aguja

Inc./PharmaJet

Vacuna de ADN

BioNet Asia

VLP

Max Planck Institute for Dynamics of Complex Technical Systems

AND

Takis/Applied DNA Sciences/Evvivax

CD8 T cell peptide targeting (S, M, N) and (NSPs) SARS-CoV-2 proteins

OSE immunotherapeutics

ADN con electroporación

Chula Vaccine Research Center

VLPs produced in BEVS

Tampere University

ADN con electroporación

Karolinska Institute / Cobra Biologics (OPENCORONA Project)